Nirsevimab Shows Promise in Protecting Infants from RSV Lower Respiratory Tract Disease
A new study confirms that nirsevimab provides strong protection for infants against RSV-related lower respiratory tract disease, significantly reducing hospitalizations and healthcare visits during the RSV season.
Recent research published in the journal Pediatrics confirms that nirsevimab is highly effective in safeguarding infants against respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRTD). The study, led by Dr. Amber Hsiao from the Kaiser Permanente Vaccine Study Center in Oakland, California, analyzed data from the 2023-2024 RSV season involving nearly 32,000 infants.
The research demonstrated that nearly half of these infants received nirsevimab, and among them, the incidence of RSV LRTD was significantly lower. Specifically, nirsevimab showed an effectiveness rate of 87.2% against RSV LRTD, 98% in preventing hospitalizations due to RSV LRTD, and 71% against PCR-confirmed RSV infections. Infants who received the medication experienced fewer healthcare encounters related to RSV and had substantially reduced odds of hospitalization.
These findings bolster the recommendations by the Advisory Committee on Immunization Practices, advocating for infants under 8 months to receive nirsevimab at the start of their first RSV season. The study underscores the potential of nirsevimab as a critical tool in reducing the burden of RSV illness in young children, providing further evidence of its role in pediatric preventive care.
For more details, the full study can be accessed through the DOI: 10.1542/peds.2024-069510.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advancements in Diagnostic Tools for Adult ADHD Detection
Research at the University of Oslo is advancing diagnostic tools to better detect ADHD in adults by studying mind wandering and brain activity patterns, aiming to improve diagnosis and treatment options.
Salmonella Outbreak Linked to Metabolic Meals Results in 16 Illnesses, CDC Reports
A Salmonella outbreak linked to Metabolic Meals has sickened 16 people across 10 states. Consumers are advised to discard affected products and seek medical attention if needed.
How Rising Body Temperatures in Animals Offer Insights for Human Fever Response
Fever serves as a vital immune defense across diverse species, from reptiles to insects, offering insights into its natural role in fighting infections and its potential in human health.
Breakthrough in Gene Therapy Stabilizes Neuropathy in Rare Nerve Disease
A groundbreaking gene editing therapy shows promise in stabilizing neuropathy symptoms and reducing disease markers in hereditary transthyretin amyloidosis, offering hope for long-term disease management.